演講者

Mohammad M. Afshar, Ariana Pharmaceuticals
Steven M. Albelda, University of Pennsylvania Medical Center
John L. Allinson, ICON Development Solutions
Lukas C. Amler, Genentech
Philip M. Arlen, Neogenix
Haifeng Bao, MedImmune
Hirak Basu, Colby Pharmaceutical Company
Farideh Z. Bischoff, Biocept
John Bloom, University of Pennsylvania
Jeffrey Chalmers, The Ohio State University
Jake Y. Chen, Indiana University School of Informatics
Rong Chen, Stanford University School of Medicine
Joshua P. Cohen, Tufts Center for the Study of Drug Development
Jason Connor, Berry Consultants
Massimo Cristofanilli, Fox Chase Cancer Center
Viswanath Devanarayan, Abbott Laboratories
Brian T. Edmonds, Eli Lilly and Co.
John T. Elliott, NIST
Hawazin Faruki, Laboratory Corporation of America
Denise L. Faustman, Harvard Medical School
Michael Forstner, Roche
Robert H. Getzenberg, The Johns Hopkins University School of Medicine
Abdel Halim, Daiichi Sankyo
David Handelsman, SAS Institute
Weili He, Merck Sharp & Dohme Corp.
Joerg Heyer, AVEO Pharmaceuticals
Axel Hoos, Bristol-Myers Squibb
Jiaqi Huang, MedImmune
Jeffrey Jackson, Bristol-Myers Squibb
Christopher Jennison, University of Bath
Maria Jure-Kunkel, Bristol-Myers Squibb
Rima Kaddurah-Daouk, Duke University Medical Center
Michael Kalos, University of Pennsylvania
Michael Krams, Johnson & Johnson
Olga Kuznetsova, Merck Sharp & Dohme Corp.
Jing Li, Merck & Co.
Lei Li, Pfizer, Inc.
Evi Lianidou, University of Athens
Y. Peng Loh, National Institutes of Health
Marek Malecki, Western University of Health Sciences
David Manner, Eli Lilly and Co.
Francesco Marincola, NIH CC
Stuart S. Martin, University of Maryland School of Medicine
Muralidhar Reddy Moola, The Scripps Research Institute
Raymond Ng, PROOF Centre of Excellence
Stafford O'Kelly, Abbott Molecular
Matthew Onsum, Merrimack Pharmaceuticals
Scott D. Patterson, Amgen
Shannon R. Payne, Epigenomics, Inc.
Eric D. Perakslis, Johnson & Johnson Pharmaceuticals R&D
Steven Piantadosi, Samuel Oschin Comprehensive Cancer Institute
Jose Pinheiro, Johnson & Johnson Pharmaceuticals R&D
Suso Platero, Centocor, Ortho Biotech Oncology R&D
Yili L. Pritchett, Abbott Laboratories
Gavin P. Robertson, Pennsylvania State University
Hakan Sakul, Pfizer
Richard K. Schatzberg, Generation Health
Jerald S. Schindler, Merck Research Laboratories
Cecilia Schott, AstraZeneca
Alex Sherman, Massachusetts General Hospital
Janet Siebert, CytoAnalytics
Thierry Sornasse, Integrated Biomarker Strategies
Shannon Stott, Massachusetts General Hospital, Harvard Medical School
Robert Umek, Meso Scale Discovery
Werner Verbiest, Johnson & Johnson
William Wachsman, University of California, San Diego School of Medicine
Lihua Wang, National Cancer Institute
Amelia Warner, Merck
Glen Weiss, Translational Genomics Research Institute
Rhonda Wideman, PROOF Centre of Excellence
Dianna Wu, Merck & Co
Yihong Yao, MedImmune
Sandra Zeckel, Eli Lilly and Co.
Baolin Zhang, U.S. Food and Drug Administration
Siyang Zheng, Pennsylvania State University